MENU
RNTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Rein Therapeutics (RNTX) Ownership - Who owns Rein Therapeutics?
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company... Show more
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
25.58M
P/E Ratio
N/A
Total Cash
7.43M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash/Share
0.32
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
RNTX
Capitalization
25.6M
P/E Ratio
N/A
Risk (Beta)
1.81
Dividend Yield
N/A
Total Cash
7.43M
Total Cash/Share
0.32
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
4.87M
P/B Ratio
5.25
Cash Flow
N/A
Earnings
-2.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
108K
Current Ratio
1.39
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-26.51M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-78.14
Shares Held By Institutions
10.9M
Shares Outstanding - Current
23M
Total Liabilities
52.8M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-51.739
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information